{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:50:29Z","timestamp":1791413429349,"version":"4.3.3"},"reference-count":40,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["116162193"],"award-info":[{"award-number":["116162193"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2581"],"award-info":[{"award-number":["2581"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AR 376\/22-1"],"award-info":[{"award-number":["AR 376\/22-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inhibitors of acid sphingomyelinase (ASM) with nanomolar in cellulo activity were developed by masking the amino bisphosphonate inhibitor ARC39. ASM is a key enzyme catalyzing the hydrolysis of sphingomyelin to ceramide, which plays a role in various physiological and pathological processes. Inhibitors of ASM have been proposed as potential treatment for disorders such as cancer and metastasis, acute lung injury, sepsis, atherosclerosis, and major depression. Despite the vital interest in ASM as a drug target, potent inhibitors of this enzyme are still urgently needed. The masked ARC39 derivatives developed in this study are 100 times more potent than the parent compound. Their properties such as cell uptake, stability, etc. were thoroughly investigated.<\/jats:p>","DOI":"10.1021\/acschembio.6c00541","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:01:47Z","timestamp":1791410507000},"source":"Crossref","is-referenced-by-count":0,"title":["Masked Bisphosphonate Inhibitors of Acid Sphingomyelinase: Improved Cell Penetration and Potency"],"prefix":"10.1021","author":[{"given":"Christian","family":"Kappe","sequence":"first","affiliation":[{"name":"Humboldt Universit\u00e4t zu Berlin , , Brook-Taylor-Str 2 , ,","place":["Berlin, Germany, 12489"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"R\u00fchling","sequence":"additional","affiliation":[{"name":"Julius-Maximilians-University W\u00fcrzburg , , ,","place":["W\u00fcrzburg, Germany, 97074"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Machlah","sequence":"additional","affiliation":[{"name":"University of Duisburg-Essen , , ,","place":["Essen, Germany, 45147"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-3275","authenticated-orcid":true,"given":"Fabian","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Freie Universit\u00e4t Berlin , , K\u00f6nigin-Luise-Str. 2+4 , ,","place":["Berlin, Germany, 14195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Russi","sequence":"additional","affiliation":[{"name":"Humboldt Universit\u00e4t zu Berlin , , Brook-Taylor-Str 2 , ,","place":["Berlin, Germany, 12489"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Naser","sequence":"additional","affiliation":[{"name":"University of Duisburg-Essen , , ,","place":["Essen, Germany, 45147"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Carpinteiro","sequence":"additional","affiliation":[{"name":"University of Duisburg-Essen , , ,","place":["Essen, Germany, 45147"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Kleuser","sequence":"additional","affiliation":[{"name":"Freie Universit\u00e4t Berlin , , K\u00f6nigin-Luise-Str. 2+4 , ,","place":["Berlin, Germany, 14195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fraunholz","sequence":"additional","affiliation":[{"name":"Julius-Maximilians-University W\u00fcrzburg , , ,","place":["W\u00fcrzburg, Germany, 97074"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-9437","authenticated-orcid":true,"given":"Christoph","family":"Arenz","sequence":"additional","affiliation":[{"name":"Humboldt Universit\u00e4t zu Berlin , , Brook-Taylor-Str 2 , ,","place":["Berlin, Germany, 12489"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"11","key":"2026100718014167400_cit1","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/(SICI)1521-3773(19990601)38:11&lt;1532::AID-ANIE1532&gt;3.0.CO;2-U","article-title":"Sphingolipids-Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases","volume":"38","author":"Kolter","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"2026100718014167400_cit2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6\u20137","key":"2026100718014167400_cit3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/hsz-2015-0109","article-title":"Secretory sphingomyelinase in health and disease","volume":"396","author":"Kornhuber","year":"2015","journal-title":"Biol. Chem."},{"issue":"5","key":"2026100718014167400_cit4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood.2020005985","article-title":"Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat","volume":"137","author":"McVey","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2026100718014167400_cit5","doi-asserted-by":"publisher","first-page":"12348","DOI":"10.1038\/s41598-017-11837-2","article-title":"Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver","volume":"7","author":"Chung","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"2026100718014167400_cit6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00109-014-1134-5","article-title":"Acid sphingomyelinase, autophagy, and atherosclerosis","volume":"92","author":"Luft","year":"2014","journal-title":"J. Mol. Med."},{"issue":"10","key":"2026100718014167400_cit7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"3","key":"2026100718014167400_cit8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell"},{"issue":"7","key":"2026100718014167400_cit9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"2026100718014167400_cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000315100","article-title":"Small molecule inhibitors of acid sphingomyelinase","volume":"26","author":"Arenz","year":"2010","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"2026100718014167400_cit11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/acs.jmedchem.0c01664","article-title":"Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network","volume":"64","author":"Skacel","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026100718014167400_cit12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026100718014167400_cit13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1515\/bchm3.1994.375.7.447","article-title":"The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts","volume":"375","author":"Hurwitz","year":"1994","journal-title":"Biol. Chem."},{"issue":"19","key":"2026100718014167400_cit14","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1016\/j.febslet.2006.07.071","article-title":"New insights on the use of desipramine as an inhibitor for acid ceramidase","volume":"580","author":"Elojeimy","year":"2006","journal-title":"FEBS Lett."},{"key":"2026100718014167400_cit15","doi-asserted-by":"publisher","first-page":"44867","DOI":"10.1038\/srep44867","article-title":"Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"2026100718014167400_cit16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acs.jmedchem.9b00739","article-title":"Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity","volume":"63","author":"Yang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026100718014167400_cit17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115082119","article-title":"Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer's disease mice","volume":"119","author":"Park","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"2026100718014167400_cit18","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1021\/acs.jmedchem.2c01643","article-title":"Discovery of Novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"41","key":"2026100718014167400_cit19","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1002\/anie.200903288","article-title":"Potent and selective inhibition of acid sphingomyelinase by bisphosphonates","volume":"48","author":"Roth","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"2026100718014167400_cit20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2119\/molmed.2016.00140","article-title":"Acid Sphingomyelinase Promotes Endothelial Stress Response in Systemic Inflammation and Sepsis","volume":"22","author":"Chung","year":"2016","journal-title":"Mol. Med."},{"key":"2026100718014167400_cit21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-7-45","article-title":"Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons","volume":"7","author":"Martinez","year":"2012","journal-title":"Mol. Neurodegen."},{"issue":"5","key":"2026100718014167400_cit22","doi-asserted-by":"publisher","first-page":"L625","DOI":"10.1152\/ajplung.00317.2016","article-title":"Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets","volume":"312","author":"McVey","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2026100718014167400_cit23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02635-2021","article-title":"Stimulation of the EP(3) receptor causes lung oedema by activation of TRPC6 in pulmonary endothelial cells","volume":"60","author":"Jiang","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"6","key":"2026100718014167400_cit24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1194\/jlr.RA120000682","article-title":"Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro","volume":"61","author":"Naser","year":"2020","journal-title":"J. Lipid Res."},{"key":"2026100718014167400_cit25","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1038\/ncomms12196","article-title":"Crystal structure of mammalian acid sphingomyelinase","volume":"7","author":"Gorelik","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"2026100718014167400_cit26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1039\/D1MD00297J","article-title":"Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions","volume":"13","author":"Rudge","year":"2022","journal-title":"RSC Med. Chem."},{"issue":"14","key":"2026100718014167400_cit27","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/cbic.200900281","article-title":"Potent inhibition of acid sphingomyelinase by phosphoinositide analogues","volume":"10","author":"Roth","year":"2009","journal-title":"ChemBioChem"},{"issue":"94","key":"2026100718014167400_cit28","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.1039\/D0CC06661C","article-title":"A photocaged inhibitor of acid sphingomyelinase","volume":"56","author":"Prause","year":"2020","journal-title":"Chem. Commun. (Camb)"},{"issue":"2","key":"2026100718014167400_cit29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0928-0987(00)00099-3","article-title":"Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate","volume":"11","author":"Niemi","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"26","key":"2026100718014167400_cit30","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1002\/chem.202000133","article-title":"A Novel Visible Range FRET Probe for Monitoring Acid Sphingomyelinase Activity in Living Cells","volume":"26","author":"Kappe","year":"2020","journal-title":"Chemistry"},{"issue":"10","key":"2026100718014167400_cit31","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1002\/anie.201611706","article-title":"Amplification of a FRET Probe by Lipid-Water Partition for the Detection of Acid Sphingomyelinase in Live Cells","volume":"56","author":"Pinkert","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"2026100718014167400_cit32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.102810.4","article-title":"A Novel Rapid Host Cell Entry Pathway Determines Intracellular Fate of Staphylococcus aureus","volume":"13","author":"R\u00fchling","year":"2026","journal-title":"Elife"},{"key":"2026100718014167400_cit33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.694489","article-title":"Staphylococcus aureus \u03b1-Toxin Induces Acid Sphingomyelinase Release From a Human Endothelial Cell Line","volume":"12","author":"Krones","year":"2021","journal-title":"Front. Microbiol."},{"issue":"Pt 1","key":"2026100718014167400_cit34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2818.2007.01755.x","article-title":"Limited utility of acetoxymethyl (AM)-based intracellular delivery systems, in vivo: interference by extracellular esterases","volume":"226","author":"Jobsis","year":"2007","journal-title":"J. Microsc."},{"key":"2026100718014167400_cit35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1159\/000341460","article-title":"Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase","volume":"30","author":"Li","year":"2012","journal-title":"Cell Phys. Biochem."},{"key":"2026100718014167400_cit36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jcf.2022.02.005","article-title":"CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis","volume":"21","author":"Westholter","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"2026100718014167400_cit37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chroma.2016.12.033","article-title":"Assay to measure sphingomyelinase and ceramidase activities efficiently and safely","volume":"1481","author":"Muhle","year":"2017","journal-title":"J. Chromatogr. A"},{"issue":"19","key":"2026100718014167400_cit38","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1021\/ac8011347","article-title":"Assessing the sensitivity of commercially available fluorophores to the intracellular environment","volume":"80","author":"Chen","year":"2008","journal-title":"Anal. Chem."},{"issue":"7","key":"2026100718014167400_cit39","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1039\/c1ob06602a","article-title":"1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase","volume":"10","author":"Szajnman","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"2026100718014167400_cit40","article-title":"Pyrrolotriazine kinase inhibitors","author":"Ping","year":"2007"}],"container-title":["ACS Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acschembio.6c00541","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acbcct\/article-pdf\/doi\/10.1021\/acschembio.6c00541\/68779455\/cb-2026-00541y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acbcct\/article-pdf\/doi\/10.1021\/acschembio.6c00541\/68779455\/cb-2026-00541y.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:09:28Z","timestamp":1791410968000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acbcct\/article\/doi\/10.1021\/acschembio.6c00541\/5446614\/Masked-Bisphosphonate-Inhibitors-of-Acid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1021\/acschembio.6c00541","relation":{},"ISSN":["1554-8929","1554-8937"],"issn-type":[{"value":"1554-8929","type":"print"},{"value":"1554-8937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}